Search
Repligen Corp
RGENAdd to Watchlist
186.750USD
+6.040+3.34%
Close 09-22 16:00（ET）
10.54BMarket Cap
204.42P/E TTM
Repligen Corp (RGEN) Stock Price Target & Forecast
Analyst Rating
Based on 22 analysts giving stock ratings to Repligen Corp in the past month.
Buy
5 Strong Buy
14 Buy
3 Hold
0 Sell
0 Strong Sell
Target Price
190.737USD+7.83%
RGEN Analyst Recommendation Trends
In the current month, RGEN has received 14 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. RGEN average Analyst price target in the last month is 190.737.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
5
5
5
5
5
5
5
14
14
14
13
13
13
13
13
3
3
4
4
4
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
22
23
22
22
22
22
22
RGEN Analyst Rating for Peer Comparison
Updated: Sep 22, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Abbott Laboratories
ABT
11
12
6
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Insulet Corp
PODD
7
8
12
0
0
27
Guardant Health Inc
GH
12
13
2
0
0
27
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
West Pharmaceutical Services Inc
WST
6
12
1
0
0
19
Financial Forecasting
Based on analysts' estimates, RGEN EPS is projected to reach 0.462 in FY2026Q3, following reported EPS of 0.089 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.44
0.39
0.45
0.46
0.58
Actual
0.24
0.15
0.09
--
--
Surprise
-46.34%
-61.70%
-80.21%
--
--
FAQs
What is Repligen Corp's expected revenue for the next quarter?
Repligen Corp's expected revenue is 206.70M.
What is Repligen Corp's price target?
Analysts forecast that Repligen Corp's price target is USD 190.74, with the highest forecast at USD 225.00 and the lowest forecast at USD 145.00.
How have Repligen CorpRGEN's recent earnings per share performed?
The market expectation was USD 0.09, while Repligen CorpRGEN's earnings per share (EPS) for the previous quarter was USD 0.15. EPS for the next quarter is expected at USD 0.46.
What is the analyst rating for Repligen Corp?
Based on the ratings of Repligen Corp's stock from 22 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.